137 related articles for article (PubMed ID: 2696022)
1. Patterns of treatment failure--implications for new treatment approaches.
Tattersall MH
Recent Results Cancer Res; 1989; 115():1-7. PubMed ID: 2696022
[No Abstract] [Full Text] [Related]
2. Randomized multicenter 2 x 2-factorial design study of chemo/endocrine therapy in operable, node-positive breast cancer (protocol 2).
Scheurlen H
Recent Results Cancer Res; 1989; 115():226-35. PubMed ID: 2696037
[No Abstract] [Full Text] [Related]
3. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Stewart HJ
Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
[No Abstract] [Full Text] [Related]
4. Salvage treatments in relapsing resectable breast cancer.
Valagussa P; Brambilla C; Zambetti M; Bonadonna G
Recent Results Cancer Res; 1989; 115():69-76. PubMed ID: 2696043
[No Abstract] [Full Text] [Related]
5. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
Boyages J; Tiver KW
Aust N Z J Surg; 1992 May; 62(5):354-63. PubMed ID: 1575655
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy in early breast cancer.
Chittoor SR; Swain SM
Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer.
Alagaratnam TT; Wong J
Aust N Z J Surg; 1986 Jan; 56(1):39-41. PubMed ID: 3090987
[TBL] [Abstract][Full Text] [Related]
8. Start tamoxifen after completing chemotherapy, US researchers say.
McCarthy M
Lancet; 2002 Jun; 359(9321):1925. PubMed ID: 12057564
[No Abstract] [Full Text] [Related]
9. Controversies in the medical management of breast cancer.
Smith IE
Postgrad Med J; 1985 Feb; 61(712):117-22. PubMed ID: 3983039
[No Abstract] [Full Text] [Related]
10. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
Kaufmann M; Jonat W; Abel U
Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
[No Abstract] [Full Text] [Related]
11. [Medical treatment of breast carcinoma].
Rosso R; Gardin G
Ann Ital Chir; 1991; 62(5):467-77. PubMed ID: 1801625
[No Abstract] [Full Text] [Related]
12. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
13. Dose response for adjuvant chemotherapy of breast cancer: experimental and clinical considerations.
Frei E
Recent Results Cancer Res; 1989; 115():25-7. PubMed ID: 2696038
[No Abstract] [Full Text] [Related]
14. The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
Gray R; Clarke M; Collins R; Peto R
Ann N Y Acad Sci; 1993 Nov; 698():339-48. PubMed ID: 8279773
[No Abstract] [Full Text] [Related]
15. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
[TBL] [Abstract][Full Text] [Related]
16. [Doxorubicin and paclitaxel versus 5-fluorouracil, doxorubicin and cyclophosphamide as first-line treatment in women with metastatic breast carcinoma: final results of a phase III multicenter randomized trial].
Amadori D; Fabbri M
Tumori; 2001; 87(5):A18-9. PubMed ID: 11765729
[No Abstract] [Full Text] [Related]
17. [A randomized trial of endocrine therapy, chemotherapy, and chemo-endocrine therapy in advanced breast cancer].
Tashiro H; Nomura Y; Hisamatsu K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2369-73. PubMed ID: 2260873
[TBL] [Abstract][Full Text] [Related]
18. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Fisher B; Brown AM; Dimitrov NV; Poisson R; Redmond C; Margolese RG; Bowman D; Wolmark N; Wickerham DL; Kardinal CG
J Clin Oncol; 1990 Sep; 8(9):1483-96. PubMed ID: 2202791
[TBL] [Abstract][Full Text] [Related]
19. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Yaal-Hahoshen N; Safra T
Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
[No Abstract] [Full Text] [Related]
20. Adjuvant systemic therapy for resectable breast cancer.
Bonadonna G; Valagussa P
J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
